An international research collaboration led by the University of Cambridge analysed existing cohort studies and randomised trials on coronary risk and fatty acid intake. They showed that current evidence does not support guidelines which restrict the consumption of saturated fats in order to prevent heart disease….
Read More »Monthly Archives: March 2014
Diabetic Foot Ulcers and the Economic Burden on Insurers
Patients with diabetic foot ulcers have an annual burden on yearly Medicare of $11,710….
Read More »Obesity Linked to Increased Ovarian Cancer Risk
An analysis of 25 population studies which focused on weight and included 4 million women, 16,000 of whom developed ovarian cancer. The report showed a dose-response relationship: a six percent increased risk of developing ovarian cancer for every 5-point increase in BMI….
Read More »No CVD Benefit for Older Patients Taking Omega-3 Fatty Acids
Taking omega-3 fatty-acid supplements for nearly five years failed to reduce the incidence of CVD mortality, MI, stroke, unstable angina, revascularization, CHF hospitalizations, and resuscitated cardiac arrest, report investigators….
Read More »Excess B Vitamins May Be Linked to Obesity
New evidence suggests that increased intake of certain vitamins, including B vitamins, may play a role in the increased prevalence of obesity in recent years….
Read More »Special GLP-1 Edition, March 2014
There is no doubt that all too many times in the past we have heard great news on non-injectable insulin drugs. First we had inhaled, which flopped and buccal which seems to be stuck in other countries except the U.S. Over the past 10 years we have had over 30 …
Read More »Alternative GLP-1 Delivery Systems
Although glucagon-like peptide-1 (GLP-1) is highly biologically active following intravenous or subcutaneous injection, a non-injectable alternative for activating GLP-1 receptor signaling would clearly be desirable. Studies by Gutniak, Ahren and colleagues in Sweden have shown that GLP-1 formulated in buccal tablets is absorbed into the circulation and lowers blood glucose …
Read More »Letter from the Editor #721:
This past Friday I had the pleasure of presenting a CE program at the annual meeting of the Washington Association of Diabetes Educators. There were 250+ diabetes educators in attendance and we were talking about the use of new technology. During the program I asked those in the room about …
Read More »Intergy
Vitera Healthcare Solutions iOS Free with Vitera Intergy EHR system Vitera Intergy Mobile is the iPad companion to Vitera Intergy EHR. Using an iPad device, you can access their appointment schedules, task lists, and patient clinical data at any time and from anywhere. Whether you are on call or on the road, …
Read More »John Anderson, MD, ADA Board of Directors, Introduction
John Anderson, MD, gives us a brief introduction to himself and talks about how, as an internal medicine specialist, he deals with a whole range of issues related to diabetes which he see in his patients. More videos with John Anderson, MD: Thoughts on SGLT-2 Inhibitors What is the ADA …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.